![Vaksin COVID-19 🇲🇾 on Twitter: "Selang masa bagi dos vaksin AstraZeneca kini telah dipendekkan ke 9 minggu daripada 12 minggu. Janji temu bagi dos kedua bagi mereka yang menerima vaksin pada inisiatif Vaksin COVID-19 🇲🇾 on Twitter: "Selang masa bagi dos vaksin AstraZeneca kini telah dipendekkan ke 9 minggu daripada 12 minggu. Janji temu bagi dos kedua bagi mereka yang menerima vaksin pada inisiatif](https://pbs.twimg.com/media/E7hPADEVoAYxZnq.jpg)
Vaksin COVID-19 🇲🇾 on Twitter: "Selang masa bagi dos vaksin AstraZeneca kini telah dipendekkan ke 9 minggu daripada 12 minggu. Janji temu bagi dos kedua bagi mereka yang menerima vaksin pada inisiatif
![Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet](https://www.thelancet.com/cms/asset/4a4effe5-53f5-4f96-9256-36262c6efc01/gr1.jpg)
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Pasig City Public Information Office - Alamin kung kailan dapat mabakunahan ng second dose ng COVID-19 vaccine! Sa mga nabakunahan na ng first dose, tingnan ang material kung gaano katagal ang DOH-recommended
![Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1088/F4.large.jpg)
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
![expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science](http://www.sciencemediacentre.org/wp-content/uploads/2021/02/Sheila-Bird-03-02-2021.png)
expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science
![Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1088/F2.large.jpg)
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
![Should I reduce the interval between my 1st and 2nd Astra Zeneca COVID 19 Vaccination doses? – Gerringong Medical Practice Should I reduce the interval between my 1st and 2nd Astra Zeneca COVID 19 Vaccination doses? – Gerringong Medical Practice](https://gerringonggp.com.au/wp-content/uploads/2021/07/Picture1.png)